4.6 Article

Structural basis for the ORC1-Cyclin A association

Journal

PROTEIN SCIENCE
Volume 28, Issue 9, Pages 1727-1733

Publisher

WILEY
DOI: 10.1002/pro.3689

Keywords

cyclin-inhibitor complex; ORC1; Cyclin A; Cyclin E; cell cycle regulation

Funding

  1. National Institute of General Medical Sciences [R35GM119721, P30 GM124165]
  2. March of Dimes Foundation [1-FY15-345]
  3. NIH-ORIP [S10OD021527]
  4. National Institutes of Health [R35GM119721]
  5. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119721, P30GM124169] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Progression of cell cycle is regulated by sequential expression of cyclins, which associate with distinct cyclin kinases to drive the transition between different cell cycle phases. The complex of Cyclin A with cyclin-dependent kinase 2 (CDK2) controls the DNA replication activity through phosphorylation of a set of chromatin factors, which critically influences the S phase transition. It has been shown that the direct interaction between the Cyclin A-CDK2 complex and origin recognition complex subunit 1 (ORC1) mediates the localization of ORC1 to centrosomes, where ORC1 inhibits cyclin E-mediated centrosome reduplication. However, the molecular basis underlying the specific recognition between ORC1 and cyclins remains elusive. Here we report the crystal structure of Cyclin A-CDK2 complex bound to a peptide derived from ORC1 at 2.54 a resolution. The structure revealed that the ORC1 peptide interacts with a hydrophobic groove, termed cyclin binding groove (CBG), of Cyclin A via a KXL motif. Distinct from other identified CBG-binding sequences, an arginine residue flanking the KXL motif of ORC1 inserts into a neighboring acidic pocket, contributing to the strong ORC1-Cyclin A association. Furthermore, structural and sequence analysis of cyclins reveals divergence on the ORC1-binding sites, which may underpin their differential ORC1-binding activities. This study provides a structural basis of the specific ORC1-cyclins recognition, with implication in development of novel inhibitors against the cyclin/CDK complexes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available